Arabic Arabic English English French French German German
dark

Adaptive Phage Therapeutics Announces Licensing Agreement with the Walter Reed Army Institute of Research

Adaptive Phage Therapeutics today announced that it has entered into a licensing agreement with The Walter Reed Army Institute of Research (WRAIR) to provide APT access to the Institute’s extensive phage database. Read More

Total
0
Shares
Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Post

SynForU(TM)-HerCare probiotics shows benefits to reduce vaginal yeast infection in pregnant women

Next Post

Relief Reports that U.S. Collaboration Partner has Announced a New Finding from Aviptadil Phase 2b/3 Trial Demonstrating Clinically Significant Relief from Respiratory Distress in Critical COVID-19

Related Posts
Total
0
Share